BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8381280)

  • 21. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
    Debernardi MA; Munshi R; Brooker G
    Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5'-monophosphate/protein kinase a second messenger system.
    Jones DC; Kuhar MJ
    J Pharmacol Exp Ther; 2006 Apr; 317(1):454-61. PubMed ID: 16322355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of cyclic AMP concentration in bovine endometrial stromal cells by arachidonic acid.
    Cheng Z; Sheldrick EL; Marshall E; Wathes DC; Abayasekara DR; Flint AP
    Reproduction; 2007 May; 133(5):1017-26. PubMed ID: 17616730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation.
    Lo HW; Ali-Osman F
    J Cell Biochem; 2002; 87(1):103-16. PubMed ID: 12210727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
    Hecker M; Preiss C; Schini-Kerth VB
    Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells.
    Bergamaschi A; Corsi M; Garnier MJ
    Cell Signal; 2006 Oct; 18(10):1679-84. PubMed ID: 16497477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabbit pigmented ciliary epithelium produces interleukin-6 in response to inflammatory cytokines.
    Fleisher LN; McGAHAN MC; Ferrell JB
    Exp Eye Res; 2000 Mar; 70(3):271-9. PubMed ID: 10712813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkylcatechols regulate NGF gene expression in astroglial cells via both protein kinase C- and cAMP-independent mechanisms.
    Furukawa Y; Furukawa S; Omae F; Awatsuji H; Hayashi K
    J Neurosci Res; 1993 Aug; 35(5):522-9. PubMed ID: 8397306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase C and adenylate cyclase as targets for growth inhibition of human gastric cancer cells.
    Piontek M; Hengels KJ; Porschen R; Strohmeyer G
    J Cancer Res Clin Oncol; 1993; 119(12):697-9. PubMed ID: 8408180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic AMP modulates interleukin-1 action in a cytotoxic T-cell hybridoma.
    Schlegel-Haueter SE; Aebischer F
    Cell Signal; 1990; 2(5):489-96. PubMed ID: 2177620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocanalicular organic-anion transport is regulated by protein kinase C.
    Roelofsen H; Ottenhoff R; Oude Elferink RP; Jansen PL
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):637-41. PubMed ID: 1716882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.
    Xiao LY; Kan WM
    Eur J Pharmacol; 2017 Jan; 794():201-208. PubMed ID: 27894809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic AMP--an intracellular second messenger for interleukin 1.
    Shirakawa F; Yamashita U; Chedid M; Mizel SB
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8201-5. PubMed ID: 2847154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells.
    Novak TJ; Rothenberg EV
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9353-7. PubMed ID: 2174560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-1beta-induced inhibition of hair growth in vitro is mediated by cyclic AMP.
    Hoffmann R; Eicheler W; Wenzel E; Happle R
    J Invest Dermatol; 1997 Jan; 108(1):40-2. PubMed ID: 8980284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second messenger pathways in lymphocyte binding and penetration through graft vascular endothelium.
    Renkonen R; Mattila P; Turunen JP; Häyry P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):110-1. PubMed ID: 1846709
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms controlling the level of receptors for tumor necrosis factor.
    Holtmann H; Brakebusch C; König M; Klocke R; Winzen R; Resch K; Wallach D
    Agents Actions; 1991 Jan; 32(1-2):106-8. PubMed ID: 1647647
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of protein kinase C and second messengers in regulation of the norepinephrine transporter.
    Bönisch H; Hammermann R; Brüss M
    Adv Pharmacol; 1998; 42():183-6. PubMed ID: 9327874
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antimutagens as modifiers of the cellular cyclase system].
    Semenov VV; Studentsova IA; Durnev AD; Seredenin SB; Vizel' AO
    Vopr Med Khim; 1994; 40(3):48-51. PubMed ID: 8079441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular superoxide dismutase and glomerular mesangial cells: its production and regulation.
    Yamada H; Adachi T; Fukatsu A; Misao S; Yamada Y; Aoki T; Miura N; Sakuma M; Nishikawa K; Futenma A; Kakumu S
    FEBS Lett; 2002 May; 519(1-3):77-81. PubMed ID: 12023021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.